Form 4: Intercontinental Exchange Executive Elizabeth King Sells Shares Under 10b5-1 Trading Plan

Elizabeth King, Global Head of Clearing & CRO at Intercontinental Exchange, Inc., sold shares of common stock on March 6, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 6, 2024, Elizabeth King, Global Head of Clearing & CRO at Intercontinental Exchange, Inc. (ICE), sold shares of ICE common stock.
• The sales were executed under a Rule 10b5-1 trading plan that was approved and became effective on December 6, 2023.
• A total of 8,878 shares were sold in multiple transactions at prices ranging from $137.56 to $138.75 per share.
• Following the reported transactions, King directly owns 13,894 shares of ICE common stock.
• This total includes 5,948 shares of common stock, 768 unvested restricted stock units (RSUs), and 7,178 unvested performance-based restricted stock units (PSUs) for which the performance period has been satisfied.
• The vesting of RSUs and PSUs occurs over a three-year period, with 33.33% of the units vesting each year.
• The satisfaction of the 2024 PSUs tied to EBITDA and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting.
• The satisfaction of the 2022, 2023 and 2024 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025, February 2026 and February 2027 respectively, and will be reported at the time of vesting.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The stock sale is disclosed via a standard Form 4 filing and was conducted under a pre-arranged 10b5-1 trading plan. There is no indication of unusual or concerning activity.

Positives

• The sales were executed under a pre-arranged 10b5-1 trading plan, which can reassure investors that the transactions were not based on insider information.

Negatives

• The sale of shares by a high-ranking executive could be perceived negatively by some investors, although the existence of the 10b5-1 plan mitigates this concern.

Risks

• While the 10b5-1 plan suggests the sales were pre-planned, continued sales by executives could create downward pressure on the stock price.
• The vesting of PSUs is contingent on future performance, introducing uncertainty regarding the actual number of shares that will be issued.

Future Outlook

The number of shares to be issued pursuant to performance-based restricted stock units (PSUs) will be determined in future periods based on the company's performance against pre-defined metrics.

Industry Context

Sales by executives are a common occurrence, and the use of a 10b5-1 plan is a standard practice to avoid insider trading concerns. Investors often monitor these filings for insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Executive stock sales are a common practice across the financial industry.
• Companies like Nasdaq, CME Group, and London Stock Exchange Group also see regular Form 4 filings from their executives.
• The use of 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations, similar to what is seen at other major exchanges and financial institutions.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price.
• The vesting of PSUs impacts employees who are recipients of these units, as their compensation is tied to the company's performance.

Next Steps

• The satisfaction of the 2024 PSUs tied to EBITDA will be determined in February 2025 and reported at the time of vesting.
• The satisfaction of the 2022, 2023 and 2024 total shareholder return performance based restricted stock units will be determined in February 2025, February 2026 and February 2027 respectively, and will be reported at the time of vesting.

Key Dates